ECO.PHARMA.SUPPLY: what changed
What changed
ECO.PHARMA.SUPPLY
NACE 47.741, Retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses
filed annual accounts (NBB)
Net result for the year
-€337,585
2024 · €62,008-€399,593
Equity
€159,479
2024 · €497,064-€337,585
Cash
€447,204
2024 · €228,824+€218,380
Balance sheet total
€2.0m
2024 · €2.9m-€909,711
Largest movements
Assets
- Receivables within one year -€959,114
down €959,114 (-40.5%), from €2.4m to €1.4m
of which Trade receivables: -€864,081
- Cash +€218,380
up €218,380 (+95.4%), from €228,824 to €447,204
mainly Receivables within one year (+€959,114) and Stocks and contracts (+€162,933)
- Stocks and contracts -€162,933
down €162,933 (-54.1%), from €301,015 to €138,082
Equity and liabilities
- Other debts -€454,147
down €454,147 (-32.2%), from €1.4m to €956,335
- Profit (loss) carried forward -€337,585
down €337,585 (-70.8%), from €476,604 to €139,019
- Trade debts -€59,685
down €59,685 (-6.7%), from €884,529 to €824,844
- Tax, wage and social debts -€58,295
down €58,295 (-46.7%), from €124,908 to €66,614
of which Remuneration and social security: -€33,024
Income statement
- Gross operating margin -€470,381
down €470,381 (-48.0%), from €980,104 to €509,724
- Staff costs -€127,856
down €127,856 (-20.3%), from €631,264 to €503,408
- Financial charges -€63,994
down €63,994 (-38.6%), from €165,927 to €101,933
- Write-downs +€52,033
up €52,033 (+49.9%), from €104,246 to €156,280
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Result 2024
€62,008
Gross operating margin
-€470,381
Staff costs
+€127,856
Depreciation
-€7,943
Write-downs
-€52,033
Other operating charges
-€3,802
Other operating items
-€59,744
Financial income
+€2,631
Financial charges
+€63,994
Taxes
-€172
Result 2025
-€337,585
raises the resultlowers the resultnot broken down further in the accounts
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
From operations
+€228,211
Investment
-€9,831
Financing
€0
Cash 2024
€228,824
From operations (derived)
+€228,211
Net result for the year
-€337,585
Depreciation
+€14,727
Stocks and contracts
+€162,933
Receivables within one year
+€959,114
Deferred charges and accrued income
+€1,148
Trade debts
-€59,685
Tax, wage and social debts
-€58,295
Other debts
-€454,147
Investment (derived)
-€9,831
Investment in fixed assets (net)
-€9,831
Cash 2025
€447,204
brings cash intakes cash out
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €2,916,983 | €2,007,272 | -€909,711 | -31.2% |
| Fixed assets | 21/28 | €11,171 | €6,275 | -€4,896 | -43.8% |
| Tangible fixed assets | 22/27 | €10,931 | €6,035 | -€4,896 | -44.8% |
| Furniture and vehicles | 24 | €10,931 | €6,035 | -€4,896 | -44.8% |
| Financial fixed assets | 28 | €240 | €240 | = | 0.0% |
| Current assets | 29/58 | €2,905,812 | €2,000,997 | -€904,815 | -31.1% |
| Stocks and contracts in progress | 3 | €301,015 | €138,082 | -€162,933 | -54.1% |
| Stocks | 30/36 | €301,015 | €138,082 | -€162,933 | -54.1% |
| Amounts receivable within one year | 40/41 | €2,370,953 | €1,411,839 | -€959,114 | -40.5% |
| Trade receivables | 40 | €2,259,596 | €1,395,515 | -€864,081 | -38.2% |
| Other amounts receivable | 41 | €111,358 | €16,324 | -€95,034 | -85.3% |
| Cash at bank and in hand | 54/58 | €228,824 | €447,204 | +€218,380 | +95.4% |
| Deferred charges and accrued income | 490/1 | €5,021 | €3,872 | -€1,148 | -22.9% |
| Total equity and liabilities | 10/49 | €2,916,983 | €2,007,272 | -€909,711 | -31.2% |
| Equity | 10/15 | €497,064 | €159,479 | -€337,585 | -67.9% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Contributions outside capital | 11 | €18,600 | €18,600 | = | 0.0% |
| Other | 1109/19 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €1,860 | €1,860 | = | 0.0% |
| Non-distributable reserves | 130/1 | €1,860 | €1,860 | = | 0.0% |
| Reserves not available under the articles | 1311 | €1,860 | €1,860 | = | 0.0% |
| Profit (loss) carried forward | 14 | €476,604 | €139,019 | -€337,585 | -70.8% |
| Amounts payable | 17/49 | €2,419,919 | €1,847,792 | -€572,126 | -23.6% |
| Amounts payable within one year | 42/48 | €2,419,919 | €1,847,792 | -€572,126 | -23.6% |
| Trade debts | 44 | €884,529 | €824,844 | -€59,685 | -6.7% |
| Suppliers | 440/4 | €884,529 | €824,844 | -€59,685 | -6.7% |
| Taxes, remuneration and social security | 45 | €124,908 | €66,614 | -€58,295 | -46.7% |
| Taxes | 450/3 | €38,464 | €13,193 | -€25,271 | -65.7% |
| Remuneration and social security | 454/9 | €86,445 | €53,421 | -€33,024 | -38.2% |
| Other amounts payable | 47/48 | €1,410,482 | €956,335 | -€454,147 | -32.2% |
| Remuneration, social security and pensions | 62 | €631,264 | €503,408 | -€127,856 | -20.3% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €6,784 | €14,727 | +€7,943 | +117% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) | 631/4 | €104,246 | €156,280 | +€52,033 | +49.9% |
| Other operating charges | 640/8 | €1,569 | €5,371 | +€3,802 | +242% |
| Non-recurring operating charges | 66A | €8,542 | €68,287 | +€59,744 | +699% |
| Gross operating margin | 9900 | €980,104 | €509,724 | -€470,381 | -48.0% |
| Operating profit (loss) | 9901 | €227,698 | -€238,348 | -€466,046 | |
| Financial income | 75/76B | €275 | €2,906 | +€2,631 | +957% |
| Recurring financial income | 75 | €275 | €455 | +€180 | +65.4% |
| Non-recurring financial income | 76B | - | €2,451 | +€2,451 | |
| Financial charges | 65/66B | €165,927 | €101,933 | -€63,994 | -38.6% |
| Recurring financial charges | 65 | €165,927 | €101,933 | -€63,994 | -38.6% |
| Profit (loss) for the period before taxes | 9903 | €62,046 | -€337,375 | -€399,421 | |
| Income taxes | 67/77 | €38 | €209 | +€172 | +455% |
| Profit (loss) for the period | 9904 | €62,008 | -€337,585 | -€399,593 | |
| Profit (loss) for the period to be appropriated | 9905 | €62,008 | -€337,585 | -€399,593 |
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Compare this company with its sector.Sector benchmark
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 7 November 2026 via checked.be.